Literature DB >> 11696278

Hepatic Encephalopathy.

Srinivasan Dasarathy1, Kevin D. Mullen.   

Abstract

A characteristic feature of the neuropsychiatric changes in hepatic encephalopathy (HE) is the potential for a complete recovery in the majority of patients. In this review, we limit our discussion to HE in individuals with chronic liver disease. The optimal approach to the management of HE includes the following elements. Provide standard supportive therapy for patients with an altered mental status. This is the mainstay of therapy in the majority of clinical situations and includes administration of parenteral fluids and nutrition, care of vascular and bladder catheters, control of self-injurious activities, and instituting aspiration precautions. Rule out or control concomitant causes of encephalopathy. The diagnosis of HE has positive and negative criteria, and ruling out other causes of change in mental status is an essential component of the diagnosis. Identify and correct the precipitating factors of HE. In the majority of patients with HE, a clearly defined precipitating factor usually is identified, and the reversal or control of these factors is a key step in management. Institute gut-cleansing and ammonia-lowering measures. These measures are based on clinical and pathogenic characteristics of HE and are aimed at neutralizing the putative encephalogenic toxins (namely ammonia).

Entities:  

Year:  2001        PMID: 11696278     DOI: 10.1007/s11938-001-0017-3

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  32 in total

Review 1.  Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants.

Authors:  L S Eriksson; H O Conn
Journal:  Hepatology       Date:  1989-08       Impact factor: 17.425

2.  Observations on the symptomatology and pathogenesis of hepatic coma.

Authors:  J M WALSHE
Journal:  Q J Med       Date:  1951-10

Review 3.  Newer approaches to therapy of hepatic encephalopathy.

Authors:  P Ferenci; A Herneth; P Steindl
Journal:  Semin Liver Dis       Date:  1996-08       Impact factor: 6.115

4.  Successful hepatic vein reconstruction in 42 consecutive living related liver transplantations.

Authors:  K Kubota; M Makuuchi; T Takayama; Y Harihara; M Watanabe; K Sano; K Hasegawa; H Kawarasaki
Journal:  Surgery       Date:  2000-07       Impact factor: 3.982

5.  Precipitating factors in genesis of hepatic coma.

Authors:  W W Faloon; G L Evans
Journal:  N Y State J Med       Date:  1970-12-01

6.  Reversal of hepatic encephalopathy and alteration in amino acid profiles after blocking a surgical splenorenal shunt by interventional radiological techniques.

Authors:  B Clarke; M J Ellis; V Leung; E Hughes; J H Meek; D J Allison; H J Hodgson
Journal:  J Hepatol       Date:  1989-05       Impact factor: 25.083

7.  Rifaximin in the treatment of chronic hepatic encephalopathy.

Authors:  A Puxeddu; M Quartini; A Massimetti; A Ferrieri
Journal:  Curr Med Res Opin       Date:  1995       Impact factor: 2.580

8.  Treatment of hepatic encephalopathy with metronidazole.

Authors:  M H Morgan; A E Read; D C Speller
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

9.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

10.  Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle.

Authors:  G Biolo; R Y Declan Fleming; R R Wolfe
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  1 in total

1.  Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.

Authors:  Josef Finsterer; Elisabeth Bernauer
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.